Home › Sunovion Pharmaceuticals Inc. And Afraxis, Inc. Announce Novel Drug Discovery Partnership
 

Keywords :   


Sunovion Pharmaceuticals Inc. And Afraxis, Inc. Announce Novel Drug Discovery Partnership

2013-09-04 07:19:53| drugdiscoveryonline News Articles

Sunovion Pharmaceuticals Inc. (Sunovion) and Afraxis, Inc. recently announced that they have signed a partnership agreement to utilize the unique Enhanced Spine Platform (ESP) developed by Afraxis, Inc. to accelerate Sunovion’s preclinical central nervous system (CNS) drug discovery process

Tags: drug partnership discovery announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »